Key result
Voltage-guided substrate modification improves freedom from arrhythmia by ~30% in persistent AF.
Why the study?
The value of additional ablation beyond pulmonary vein isolation for AF is unclear, especially for persistent AF, and the optimal substrate modification target remains uncertain.
Does voltage-guided substrate modification targeting low-voltage areas improve freedom from arrhythmia in patients undergoing catheter ablation for atrial fibrillation?
Population
539 AF patients undergoing catheter ablation across four randomized studies
Comparison
Voltage-guided substrate modification targeting LVA vs conventional ablation approaches not targeting LVA
Design
Systematic review and meta-analysis of randomized studies
Authors
Loading...
Supports voltage-guided substrate modification in persistent AF ablation; strengthens pooled randomized evidence for targeted strategies.
Meta-Analysis (n=539)
Does voltage-guided substrate modification targeting low-voltage areas improve freedom from arrhythmia in patients undergoing catheter ablation for atrial fibrillation?
Effect estimate: RR 1.30 (95% CI 1.03-1.64)
Voltage-guided substrate modification targeting low-voltage areas during catheter ablation improves freedom from arrhythmia in patients with persistent, but not paroxysmal, atrial fibrillation.
Junarta et al. (2022) conducted a meta-analysis in Atrial fibrillation (n=539). Voltage-guided substrate modification targeting low-voltage areas (LVA) vs. Conventional ablation approaches not targeting LVA was evaluated on Freedom from arrhythmia (FFA) in patients with persistent AF (RR 1.30, 95% CI 1.03-1.64). Voltage-guided substrate modification targeting low-voltage areas improved freedom from arrhythmia in patients with persistent atrial fibrillation (RR 1.30; 95% CI 1.03-1.64).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: